INTERNATIONAL PATENT: INTERCEPT PHARMACEUTICALS, INC. FILES APPLICATION FOR "CRYSTALLINE FORMS OF A FARNESOID X RECEPTOR AGONIST"

GENEVA, Nov. 25 -- INTERCEPT PHARMACEUTICALS, INC. (305 Madison AvenueMorristown, New Jersey 07960) filed a patent application (PCT/US2025/029444) for "CRYSTALLINE FORMS OF A FARNESOID X RECEPTOR AGONIST" on May 14, 2025. With publication no. WO/2025/240669, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): YANIK, Mathew (c/o INTERCEPT PHARMACEUTICALS, INC.305 Madison AvenueMorristown, New Jersey 07960)

Abstract: Provided are crystalline forms of a farnesoid x receptor agonist, compositions comprising the same, and methods...